Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Millendo Therapeutics to Present at the Stifel 2019 Healthcare Conference


Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments primarily for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19, 2019 at 9:45 a.m. EST.

A live webcast of the presentation will be available on the Investors & Media section of Millendo's website at http://investors.millendo.com. A replay of the webcast will be archived on Millendo's website for 30 days following the presentation.

About Millendo Therapeutics, Inc.
Millendo Therapeutics is a late-stage biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. As a leading orphan endocrine company, Millendo creates distinct and transformative treatments where there is a significant unmet medical need. The company is currently advancing livoletide for the treatment of Prader-Willi syndrome, nevanimibe for the treatment of classic congenital adrenal hyperplasia and MLE-301 for the treatment of vasomotor symptoms associated with menopause. For more information, please visit www.millendo.com.


These press releases may also interest you

at 03:00
Sirona Biochem Corp. (US-OTC: SRBCF) ("Sirona") is excited to announce its French subsidiary lab TFChem has initiated an antiviral program to produce potential new antiviral agents to assist in combating COVID-19 and other infectious diseases....

at 03:00
March sees the official release of Harmonica Linea, a natural dietary supplement for fast yet safe weight loss. Despite not appearing on the shelves yet, it is already available for ordering on the official website....

at 02:58
Sasol welcomes and fully supports the directives announced by South African President Cyril Ramaphosa on 23 March 2020, to combat the spread of COVID-19 in South Africa, including a three-week country-wide lockdown ("the COVID-19 directives"), which...

at 02:56
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install the radiology and breast imaging modules of its enterprise imaging solution at MetroHealth. The Sectra solution, integrated with Epic Radiant, will allow...

at 02:50
The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see the company's press releases on 19 February and 16 March 2020). Through the share issue, the number of...

at 02:13
InDex Pharmaceuticals Holding AB (publ) today announced that SEK 2.0 million has been granted from Sweden's innovation agency Vinnova to develop new, more effective and safer treatments for inflammatory diseases. The grant from Vinnova within the...



News published on 11 november 2019 at 08:35 and distributed by: